Steffen Schmitz-Valckenberg, Acucela (F), Alcon/Novartis (C), Alcon/Novartis (F), Alcon/Novartis (R), Allergan (C), Allergan (F), Allergan (R), Bayer (F), Bayer (R), Bioeq/Formycon (C), Bioeq/Formycon (F), Centervue (F), Galimedix (C), Genentech/Roche (F), Genentech/Roche (R), Heidelberg Engineering (F), Katairo (F), Optos (F);
Monika Fleckenstein, Alcon/Novartis (F), Alcon/Novartis (R), Bayer (F), Bayer (R), Carl Zeiss MediTec (F), Centervue (F), Heidelberg Engineering (F), Heidelberg Engineering (R), Roche (C), US20140303013 A1 (P);
Leon von der Emde, Carl Zeiss MediTec (F), Centervue (F), Heidelberg Engineering (F), Optos (F);
Chantal Dysli, Carl Zeiss MediTec (F), Centervue (F), Heidelberg Engineering (F), Optos (F);
Sarah Thiele, Bayer (R), Carl Zeiss MediTec (F), Centervue (F), Heidelberg Engineering (F), Heidelberg Engineering (R), Novartis (F), Optos (F);
Philipp Möller, Carl Zeiss MediTec (F), Centervue (F), Heidelberg Engineering (F), Optos (F);
Moritz Lindner, Allergan (F), Carl Zeiss MediTec (F), Centervue (F), Genentech (F), Heidelberg Engineering (F), Optos (F);
Jennifer Nadal, Genentech (F);
Matthias Schmid, Bayer (C), Galimedix (C);
Frank Holz, Acucela (C), Acucela (R), Acucela (F), Allergan (F), Allergan (R), Appelis (C), Appelis (R), Bayer (C), Bayer (F), Bayer (R), Bioeq/Formycon (C), Bioeq/Formycon (F), Boehringer-Ingelheim (C), Centervue (F), Ellex (R), Galimedix (C), Geuder (C), Grayburg Vision (C), Grayburg Vision (R), Heidelberg Engineering (F), Heidelberg Engineering (C), Heidelberg Engineering (R), Roche/Genentech (F), Roche/Genentech (C), Roche/Genentech (R);
Maximilian Pfau, Carl Zeiss MediTec (F), Centervue (F), Heidelberg Engineering (F), Novartis (F), Optos (F)